Gábor Máté1, István Kertész1, Kata Nóra Enyedi2, Gábor Mező2, János Angyal3, Nikolett Vasas4, Adrienn Kis1, Éva Szabó3, Miklós Emri1, Tamás Bíró4, László Galuska1, György Trencsényi5. 1. Department of Nuclear Medicine, University of Debrecen, Hungary. 2. MTA-ELTE, Research Group of Peptide Chemistry, Hungarian Academy of Sciences, Eötvös L. University, Budapest, Hungary. 3. Department of Periodontology, University of Debrecen, Debrecen, Hungary. 4. Department of Physiology, University of Debrecen, Debrecen, Hungary. 5. Department of Nuclear Medicine, University of Debrecen, Hungary; Scanomed LTD, Debrecen, Hungary. Electronic address: trencsenyi.gyorgy@med.unideb.hu.
Abstract
PURPOSE: Aminopeptidase N (APN/CD13) plays an important role in tumor neoangiogenic process and the development of metastases. Furthermore, it may serve as a potential target for cancer diagnosis and therapy. Previous studies have already shown that asparagine-glycine-arginine (NGR) peptides specifically bind to APN/CD13. The aim of the study was to synthesize and investigate the APN/CD13 specificity of a novel (68)Ga-labeled NOTA-c(NGR) molecule in vivo using miniPET. METHODS: c[KNGRE]-NH2 peptide was conjugated with p-SCN-Bn-NOTA and was labeled with Ga-68 ((68)Ga-NOTA-c(NGR)). Orthotopic and heterotopic transplanted mesoblastic nephroma (NeDe) bearing Fischer-344 rats were prepared, on which biodistribution studies and miniPET scans were performed for both (68)Ga-NOTA-c(NGR) and ανβ3 integrin selective (68)Ga-NODAGA-[c(RGD)]2 tracers. APN/CD13 receptor expression of NeDe tumors and metastases was analyzed by western blot. RESULTS: (68)Ga-NOTA-c(NGR) was produced with high specific activity (5.13-5.92GBq/μmol) and with excellent radiochemical purity (95%<), at all cases. Biodistribution studies in normal rats showed that uptake of the (68)Ga-NOTA-c(NGR) was significantly (p⩽0.05) lower in abdominal organs in comparison with (68)Ga-NODAGA-[c(RGD)]2. Both radiotracers were mainly excreted from the kidney. In NeDe tumor bearing rats higher (68)Ga-NOTA-c(NGR) accumulation was found in the tumors than that of the (68)Ga-NODAGA-[c(RGD)]2. Using orthotopic transplantation, metastases were developed which showed specific (68)Ga-NOTA-c(NGR) uptake. Western blot analysis confirmed the presence of APN/CD13 expression in NeDe tumors and metastases. CONCLUSION: Our novel radiotracer (68)Ga-NOTA-c(NGR) showed specific binding to the APN/CD13 expressed ortho- and heterotopic transplanted NeDe tumors. Therefore, (68)Ga-NOTA-c(NGR) is a suitable tracer for the detection of APN/CD13 positive tumors and metastases in vivo.
PURPOSE:Aminopeptidase N (APN/CD13) plays an important role in tumor neoangiogenic process and the development of metastases. Furthermore, it may serve as a potential target for cancer diagnosis and therapy. Previous studies have already shown that asparagine-glycine-arginine (NGR) peptides specifically bind to APN/CD13. The aim of the study was to synthesize and investigate the APN/CD13 specificity of a novel (68)Ga-labeled NOTA-c(NGR) molecule in vivo using miniPET. METHODS: c[KNGRE]-NH2 peptide was conjugated with p-SCN-Bn-NOTA and was labeled with Ga-68 ((68)Ga-NOTA-c(NGR)). Orthotopic and heterotopic transplanted mesoblastic nephroma (NeDe) bearing Fischer-344 rats were prepared, on which biodistribution studies and miniPET scans were performed for both (68)Ga-NOTA-c(NGR) and ανβ3 integrin selective (68)Ga-NODAGA-[c(RGD)]2 tracers. APN/CD13 receptor expression of NeDe tumors and metastases was analyzed by western blot. RESULTS: (68)Ga-NOTA-c(NGR) was produced with high specific activity (5.13-5.92GBq/μmol) and with excellent radiochemical purity (95%<), at all cases. Biodistribution studies in normal rats showed that uptake of the (68)Ga-NOTA-c(NGR) was significantly (p⩽0.05) lower in abdominal organs in comparison with (68)Ga-NODAGA-[c(RGD)]2. Both radiotracers were mainly excreted from the kidney. In NeDe tumor bearing rats higher (68)Ga-NOTA-c(NGR) accumulation was found in the tumors than that of the (68)Ga-NODAGA-[c(RGD)]2. Using orthotopic transplantation, metastases were developed which showed specific (68)Ga-NOTA-c(NGR) uptake. Western blot analysis confirmed the presence of APN/CD13 expression in NeDe tumors and metastases. CONCLUSION: Our novel radiotracer (68)Ga-NOTA-c(NGR) showed specific binding to the APN/CD13 expressed ortho- and heterotopic transplanted NeDe tumors. Therefore, (68)Ga-NOTA-c(NGR) is a suitable tracer for the detection of APN/CD13 positive tumors and metastases in vivo.
Authors: János Hunyadi; György Trencsényi; Gergely Farkasinszky; Noémi Dénes; Szilvia Rácz; Adrienn Kis; Judit Szabó Péliné; Gábor Opposits; Gergő Veres; László Balkay; István Kertész; Gábor Mező Journal: In Vivo Date: 2022 Mar-Apr Impact factor: 2.155
Authors: Janine Stucke-Ring; Julian Ronnacker; Caroline Brand; Carsten Höltke; Christoph Schliemann; Torsten Kessler; Lars Henning Schmidt; Saliha Harrach; Verena Mantke; Heike Hintelmann; Wolfgang Hartmann; Eva Wardelmann; Georg Lenz; Bernhard Wünsch; Carsten Müller-Tidow; Rolf M Mesters; Christian Schwöppe; Wolfgang E Berdel Journal: Oncotarget Date: 2016-12-13
Authors: István Kertész; András Vida; Gábor Nagy; Miklós Emri; Antal Farkas; Adrienn Kis; János Angyal; Noémi Dénes; Judit P Szabó; Tünde Kovács; Péter Bai; György Trencsényi Journal: J Cancer Date: 2017-02-25 Impact factor: 4.207
Authors: Andrea Angelo Pierluigi Tripodi; Ivan Ranđelović; Beáta Biri-Kovács; Bálint Szeder; Gábor Mező; József Tóvári Journal: Pathol Oncol Res Date: 2019-12-09 Impact factor: 3.201